Jack McGuire becomes head of Whatman BioScience
Whatman plc announced today that it will acquire the assets of HemaSure Inc, subject to HemaSure Inc shareholder approval. As part of this deal Whatman has retained all of HemaSure's key personnel including, in particular, HemaSure's former President and Chief Executive Jack McGuire. Jack will become Head of Whatman BioScience which was created to commercialise Whatman's technologies for the isolation, storage and purification of DNA.
Jack has spent his entire career in sales and marketing in healthcare businesses. Prior to joining HemaSure in 1997 he served as Vice President and General Manager of Johnson & Johnson's (J&J) Ortho Diagnostic Systems Blood Bank business. He had joined J&J from Dupont in 1988, as Marketing Director for the AIDS and Hepatitis Business Unit. He held various other positions in J&J including 4 years in the UK as Managing Director of Ortho Diagnostic Systems.
Jack has a B.S. in Chemistry, an MBA from Harvard University and served as a captain in the U.S. Marine Corps.
David Smith, Chief Executive of Whatman plc, commented: “I am absolutely delighted to have Jack join Whatman's Executive Team. His drive and enthusiasm, together with his proven business and managerial skills will give our BioScience business a considerable boost.”
Jack McGuire commented: “I am extremely pleased and honoured to join Whatman as Head of BioScience. The highly innovative technology for DNA and RNA separation, purification and storage comes at a time when the use of genetic testing methodologies is exploding and in need of better enabling capabilities. Whatman is uniquely positioned to play a major role in this rapidly expanding opportunity.”
Other news from the department people
